Начало・Списък с акции・Royalty Pharma PLC (Class A)

Royalty Pharma PLC (Class A)

Затворен

СекторЗдравеопазване

57.74 1.98

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

56.53

Максимум

58.01

Ключови измерители
By Trading Economics
Приходи	-61M 295M
Продажби	8.6M 631M
P/E Средно за сектора	30.09 68.51
EPS	1.3
Дивидентна доходност	1.53
Марж на печалбата	46.733
Служители	100
EBITDA	112M 563M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+17.14% upside

Дивиденти
By Acuity
Дивидентна доходност Средно за сектора	1.53% 2.29%
Следващи печалби	4.11.2026 г.
Следваща дата на дивидент	10.09.2026 г.
Следваща дата на екс-дивидент	14.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	3.2B 33B
Предишно отваряне	55.76
Предишно затваряне	57.74

Настроения в новините

By Acuity

81%

19%

307 / 340 Класиране в Healthcare

Royalty Pharma PLC (Class A) Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

7.08.2026 г., 23:41 ч. UTC

Royalty Pharma PLC shares are higher in after-market hours, reflecting notable gains since Friday's close amid a shift toward a dovish monetary policy outlook.

6.08.2026 г., 23:01 ч. UTC

Royalty Pharma PLC shares are higher in after-market trading, moving above Thursday's close, despite remaining below the 20-day moving average.

5.08.2026 г., 19:31 ч. UTC

News

Royalty Pharma PLC raised its full-year guidance for Portfolio Receipts to $3.4 billion to $3.5 billion, contributing to a higher trading session.

4.08.2026 г., 19:26 ч. UTC

Royalty Pharma PLC shares are higher today, rebounding after earlier pulling back from a session high. The stock has fluctuated within a routine range.

3.08.2026 г., 23:46 ч. UTC

Royalty Pharma PLC shares are near unchanged in after-market trading, reflecting minimal movement since Monday's close and remaining below the 20-day moving average.

1.08.2026 г., 00:03 ч. UTC

Royalty Pharma PLC shares are lower in after-market hours, continuing a decline over the past four sessions. No specific news was identified to explain the move.

31.07.2026 г., 23:01 ч. UTC

Royalty Pharma PLC shares are lower in after-market hours, reflecting broader market trends despite some gains in mega-cap stocks. The stock remains below its 20-day moving average.

30.07.2026 г., 22:01 ч. UTC

Royalty Pharma PLC shares are higher in after-market trading, reflecting strong demand and trading above its 20-day moving average. No specific news was identified.

29.07.2026 г., 19:27 ч. UTC

Royalty Pharma PLC shares are lower today, reflecting a pullback since Tuesday's close amid rising oil prices and inflation concerns.

28.07.2026 г., 23:46 ч. UTC

Royalty Pharma PLC shares are lower in after-market trading, reflecting broader market declines amid concerns over technology sector dynamics.

27.07.2026 г., 16:46 ч. UTC

Royalty Pharma PLC shares are advancing during Monday's session. Broader market gains are supported by a notable decline in oil prices amid easing geopolitical tensions.

24.07.2026 г., 22:21 ч. UTC

In after-market trading, Royalty Pharma PLC is trading higher, nearing the upper end of its one-month range after recovering from an early low.

22.07.2026 г., 19:11 ч. UTC

News

Event

Royalty Pharma acquires a royalty interest in AstraZeneca's cliramitug for up to $425 million, including $125 million upfront payment. Shares are trading roughly flat.

21.07.2026 г., 17:51 ч. UTC

Royalty Pharma PLC shares are higher today, tracking broader market gains, with unusually high trading volume noted. No specific news was identified for the movement.

20.07.2026 г., 19:21 ч. UTC

Royalty Pharma PLC shares are lower as the Pharmaceuticals sector faces downward pressure, with unusually high trading volume noted today.

Сравнение с други в отрасъла

Ценова промяна

Royalty Pharma PLC (Class A) Прогноза

Ценова цел

By TipRanks

17.14% нагоре

12-месечна прогноза

Среден 66.5 USD 17.14%

Висок 70 USD

Нисък 65 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Royalty Pharma PLC (Class A) през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

5 ratings

Купи

Задържане

Продай

Според 5 анализатори, дали борсови рейтинги на Royalty Pharma PLC (Class A) през последните 3 месеца.

Настроение

By Acuity

307 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Royalty Pharma PLC (Class A)

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.